周三,Guggenheim对Spring Works Therapeutics (NASDAQ:SWTX)保持积极展望,同时调整了公司的目标价。该公司分析师Michael Schmidt将目标价从之前的80美元下调至78美元,同时重申对该股票的买入评级。目前市值30.6亿美元的Spring Works Therapeutics在过去一周内上涨了14%,显示出强劲势头。
BEIJING, Jan. 3 (Xinhua) -- China's central bank said on Friday it will effectively implement various existing structural monetary policy tools, as part of its work to promote the development of new ...
China also unveiled the emblem for its 2024-2025 SCO rotating presidency on Thursday. It features elements of Chinese culture, including Chinese bronzeware patterns, as well as the slogan "Upholding ...